An intravenous infusion of magnesium sulphate along with conventional medications gives an additional benefit for children who require an emergency room visit because of a severe asthma attack. Looking at clinical trials involving 182 children, researchers in Hong Kong analyzed the effects of intravenous magnesium sulphate with or without inhaled beta-2-agonist bronchodilators and oral steroid drugs.
The goal of the study was to determine if the treatment prevented the children from being hospitalized. The researchers also saw a major improvement with magnesium treatment in short-term lung function tests and symptom scores. "Intravenous magnesium sulphate is likely to be effective in avoiding hospitalization and improving bronchoconstriction and clinical symptoms of moderate-tosevere acute asthma in children, when added to standard therapies of inhaled bronchodilators and systemic steroids,"concluded the researchers in the Archives of Disease in Childhood (January 2005).
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs